Literature DB >> 25987169

Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening.

Sandra D K Kingma1, Olaf A Bodamer2, Frits A Wijburg3.   

Abstract

The lysosomal storage disorders (LSDs) are a group of genetic disorders resulting from defective lysosomal metabolism and subsequent accumulation of substrates. Patients present with a large phenotypic spectrum of disease manifestations that are generally not specific for LSDs, leading to considerable diagnostic delay and missed cases. Introduction of new disease modifying therapies for LSDs has made early diagnosis a priority. Increased awareness, but particularly the introduction of screening programs allow for early diagnosis and timely initiation of treatment. This review will provide insight into the epidemiology and diagnostic process for LSDs. In addition, challenges for carrier screening, high-risk screening and newborn population screening for LSDs are discussed.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  carrier screening; diagnosis; epidemiology; high-risk screening; lysosomal storage disorders; newborn screening

Mesh:

Year:  2014        PMID: 25987169     DOI: 10.1016/j.beem.2014.08.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  30 in total

Review 1.  [Lysosomal storage diseases: A brief summary].

Authors:  A Bornemann; Klaus Harzer
Journal:  Pathologe       Date:  2015-09       Impact factor: 1.011

Review 2.  Emptying the stores: lysosomal diseases and therapeutic strategies.

Authors:  Frances M Platt
Journal:  Nat Rev Drug Discov       Date:  2017-11-17       Impact factor: 84.694

3.  Neuronal network dysfunction precedes storage and neurodegeneration in a lysosomal storage disorder.

Authors:  Rebecca C Ahrens-Nicklas; Luis Tecedor; Arron F Hall; Elena Lysenko; Akiva S Cohen; Beverly L Davidson; Eric D Marsh
Journal:  JCI Insight       Date:  2019-11-01

4.  A mutation map for human glycoside hydrolase genes.

Authors:  Lars Hansen; Diab M Husein; Birthe Gericke; Torben Hansen; Oluf Pedersen; Mitali A Tambe; Hudson H Freeze; Hassan Y Naim; Bernard Henrissat; Hans H Wandall; Henrik Clausen; Eric P Bennett
Journal:  Glycobiology       Date:  2020-07-16       Impact factor: 4.313

Review 5.  Disease models for the development of therapies for lysosomal storage diseases.

Authors:  Miao Xu; Omid Motabar; Marc Ferrer; Juan J Marugan; Wei Zheng; Elizabeth A Ottinger
Journal:  Ann N Y Acad Sci       Date:  2016-05-04       Impact factor: 5.691

6.  Burden of Illness in Acid Sphingomyelinase Deficiency: A Retrospective Chart Review of 100 Patients.

Authors:  Gerald F Cox; Lorne A Clarke; Roberto Giugliani; Margaret M McGovern
Journal:  JIMD Rep       Date:  2018-07-12

Review 7.  Lysosomes Mediate Benefits of Intermittent Fasting in Cardiometabolic Disease: The Janitor Is the Undercover Boss.

Authors:  Kartik Mani; Ali Javaheri; Abhinav Diwan
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

8.  Prospective study of the natural history of chronic acid sphingomyelinase deficiency in children and adults: eleven years of observation.

Authors:  Margaret M McGovern; Melissa P Wasserstein; Bruno Bembi; Roberto Giugliani; K Eugen Mengel; Marie T Vanier; Qi Zhang; M Judith Peterschmitt
Journal:  Orphanet J Rare Dis       Date:  2021-05-10       Impact factor: 4.123

9.  The Spectrum of Movement Disorders in Childhood-Onset Lysosomal Storage Diseases.

Authors:  Darius Ebrahimi-Fakhari; Clara Hildebrandt; Peter E Davis; Lance H Rodan; Irina Anselm; Olaf Bodamer
Journal:  Mov Disord Clin Pract       Date:  2017-12-10

10.  Temporospatial Development of Neuropathologic Findings in a Canine Model of Mucopolysaccharidosis IIIB.

Authors:  Tyler A Harm; Shannon J Hostetter; Ariel S Nenninger; Bethann N Valentine; N Matthew Ellinwood; Jodi D Smith
Journal:  Vet Pathol       Date:  2020-11-18       Impact factor: 2.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.